Accumulation of the neurotoxic proteolytic derivative of amyloid beta precursor protein (APP), amyloid-beta (Aβ) peptide, is proposed to be key to the pathogenesis of Alzheimer’s disease (AD) (Hardy and Selkoe, 2002). This evidence concerns the gene APP and Alzheimer disease.